Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

608 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The 2023 revised diagnostic criteria for IgG4-related dacryoadenitis and sialadenitis.
Kanda M, Nagahata K, Moriyama M, Takano KI, Kamekura R, Yoshifuji H, Tsuboi H, Yamamoto M, Umehara H, Umeda M, Sakamoto M, Maehara T, Inoue Y, Kubo S, Himi T, Origuchi T, Masaki Y, Mimori T, Dobashi H, Tanaka Y, Nakamura S, Takahashi H. Kanda M, et al. Among authors: mimori t. Mod Rheumatol. 2024 Oct 23:roae096. doi: 10.1093/mr/roae096. Online ahead of print. Mod Rheumatol. 2024. PMID: 39441008
Second malignancy in advanced or recurrent non-small cell lung cancer after the advent of molecular targeted drugs and immunotherapy.
Masui Y, Shukuya T, Kataoka S, Shiozaki H, Kurokawa K, Nakamura I, Miyawaki T, Koinuma Y, Asao T, Kanemaru R, Shimamura SS, Mimori T, Mitsuishi Y, Tajima K, Shimada N, Takahashi K. Masui Y, et al. Among authors: mimori t. Thorac Cancer. 2024 Nov;15(32):2291-2297. doi: 10.1111/1759-7714.15457. Epub 2024 Oct 7. Thorac Cancer. 2024. PMID: 39375951 Free PMC article.
Anti-interferon gamma-inducible protein 16 antibodies: Identification of a novel autoantigen in idiopathic interstitial pneumonia and its clinical characteristics based on a multicenter cohort study.
Sasai T, Nakashima R, Handa T, Yamano Y, Kondo Y, Matsuda S, Kotani T, Tomioka H, Tachikawa R, Tomii K, Tanizawa K, Nohda Y, Kogame T, Shirakashi M, Hiwa R, Tsuji H, Akizuki S, Yoshifuji H, Mimori T, Kabashima K, Morinobu A. Sasai T, et al. Among authors: mimori t. Clin Immunol. 2024 Nov;268:110372. doi: 10.1016/j.clim.2024.110372. Epub 2024 Sep 30. Clin Immunol. 2024. PMID: 39357632 Free article.
Reflecting on a decade of the international consensus on ANA patterns (ICAP): Accomplishments and challenges from the perspective of the 7th ICAP workshop.
Andrade LEC, Klotz W, Herold M, Musset L, Damoiseaux J, Infantino M, Carballo OG, Choi M, von Mühlen CA, Garcia-De La Torre I, Satoh M, Francescantonio PLC, Mimori T, Conrad K, de Melo Cruvinel W, Chan EKL, Fritzler MJ. Andrade LEC, et al. Among authors: mimori t. Autoimmun Rev. 2024 Sep;23(9):103608. doi: 10.1016/j.autrev.2024.103608. Epub 2024 Aug 24. Autoimmun Rev. 2024. PMID: 39187221 Review.
Muscle Tissue Transcriptome of Idiopathic Inflammatory Myopathy Reflects the Muscle Damage Process by Monocytes and Presence of Skin Lesions.
Izuka S, Umezawa N, Komai T, Sugimori Y, Kimura N, Mizoguchi F, Fujieda Y, Ninagawa K, Iwasaki T, Suzuki K, Takeuchi T, Ohmura K, Mimori T, Atsumi T, Kawakami E, Suzuki A, Kochi Y, Yamamoto K, Yasuda S, Okamura T, Ota M, Fujio K. Izuka S, et al. Among authors: mimori t. Arthritis Rheumatol. 2025 Jan;77(1):99-106. doi: 10.1002/art.42972. Epub 2024 Sep 3. Arthritis Rheumatol. 2025. PMID: 39162115 Free PMC article.
Differences in the autoantibody phenotypes and long-term outcomes between juvenile- and adult-idiopathic inflammatory myopathies.
Tsuji H, Nakashima R, Yasumi T, Sasai T, Ichimura Y, Shirakashi M, Onizawa H, Hiwa R, Kitagori K, Akizuki S, Onishi A, Yoshifuji H, Tanaka M, Okiyama N, Mimori T, Morinobu A. Tsuji H, et al. Among authors: mimori t. Semin Arthritis Rheum. 2024 Oct;68:152530. doi: 10.1016/j.semarthrit.2024.152530. Epub 2024 Aug 8. Semin Arthritis Rheum. 2024. PMID: 39142036
Trophoblast Cell Surface Antigen 2 Expression in Thymic Carcinoma: Brief Report.
Kurokawa K, Asao T, Hayashi T, Kishikawa S, Kanamori K, Shukuya T, Miyashita Y, Nakamura I, Miyawaki T, Kanemaru R, Mimori T, Mitsuishi Y, Tajima K, Shimada N, Takahashi F, Takamochi K, Suzuki K, Takahashi K. Kurokawa K, et al. Among authors: mimori t. JTO Clin Res Rep. 2024 May 29;5(7):100693. doi: 10.1016/j.jtocrr.2024.100693. eCollection 2024 Jul. JTO Clin Res Rep. 2024. PMID: 39034967 Free PMC article.
Amivantamab plus Lazertinib in Previously Untreated EGFR-Mutated Advanced NSCLC.
Cho BC, Lu S, Felip E, Spira AI, Girard N, Lee JS, Lee SH, Ostapenko Y, Danchaivijitr P, Liu B, Alip A, Korbenfeld E, Mourão Dias J, Besse B, Lee KH, Xiong H, How SH, Cheng Y, Chang GC, Yoshioka H, Yang JC, Thomas M, Nguyen D, Ou SI, Mukhedkar S, Prabhash K, D'Arcangelo M, Alatorre-Alexander J, Vázquez Limón JC, Alves S, Stroyakovskiy D, Peregudova M, Şendur MAN, Yazici O, Califano R, Gutiérrez Calderón V, de Marinis F, Passaro A, Kim SW, Gadgeel SM, Xie J, Sun T, Martinez M, Ennis M, Fennema E, Daksh M, Millington D, Leconte I, Iwasawa R, Lorenzini P, Baig M, Shah S, Bauml JM, Shreeve SM, Sethi S, Knoblauch RE, Hayashi H; MARIPOSA Investigators. Cho BC, et al. N Engl J Med. 2024 Oct 24;391(16):1486-1498. doi: 10.1056/NEJMoa2403614. Epub 2024 Jun 26. N Engl J Med. 2024. PMID: 38924756 Clinical Trial.
608 results